-
1
-
-
0041909924
-
Drug-resistant proteins in breast cancer: Recent progress in multidrug resistance
-
Wu DL, Huang F, Lu HZ. Drug-resistant proteins in breast cancer: Recent progress in multidrug resistance. cancer (chinese), 2003, 22: 441-444.
-
(2003)
Cancer (chinese)
, vol.22
, pp. 441-444
-
-
Wu, D.L.1
Huang, F.2
Lu, H.Z.3
-
2
-
-
0030894557
-
Daunorubicin-albumin conjugate reverses resistance in multidrug resistant KB/VCR cells to daunorubicin
-
Wu DL, Li MJ, Gao HZ, et al. Daunorubicin-albumin conjugate reverses resistance in multidrug resistant KB/VCR cells to daunorubicin. Chin J Phar and Tox (Chinese), 1997, 1: 54-58.
-
(1997)
Chin J Phar and Tox (Chinese)
, vol.1
, pp. 54-58
-
-
Wu, D.L.1
Li, M.J.2
Gao, H.Z.3
-
3
-
-
33745746815
-
Pharmacological strategies for overcoming multidrug resistance
-
Nobili S, Landini I, Giglioni B, et al. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets, 2006, 7: 861-879.
-
(2006)
Curr Drug Targets
, vol.7
, pp. 861-879
-
-
Nobili, S.1
Landini, I.2
Giglioni, B.3
-
4
-
-
33644860579
-
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy
-
Takara K, Sakaeda T, Okumura K. An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy. Curr Pharm Des, 2006, 3: 273-286.
-
(2006)
Curr Pharm Des
, vol.3
, pp. 273-286
-
-
Takara, K.1
Sakaeda, T.2
Okumura, K.3
-
5
-
-
0036297864
-
Reversal of resistance of multidrug resistant MCF/Dox cell line to doxorubicin by a benflumetol derivative LY980503
-
Wu DL, Lu HZ, Huang F, et al. Reversal of resistance of multidrug resistant MCF/Dox cell line to doxorubicin by a benflumetol derivative LY980503. Chin J Phar and Tox (Chinese), 2002, 3: 211-215.
-
(2002)
Chin J Phar and Tox (Chinese)
, vol.3
, pp. 211-215
-
-
Wu, D.L.1
Lu, H.Z.2
Huang, F.3
-
6
-
-
36849061127
-
The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells
-
Liu F, Xie ZH, Cai GP, et al. The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells. Biol Pharm Bull, 2007, 12: 2279-2283.
-
(2007)
Biol Pharm Bull
, vol.12
, pp. 2279-2283
-
-
Liu, F.1
Xie, Z.H.2
Cai, G.P.3
-
7
-
-
45749103718
-
Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives
-
Yan F, Jiang Y, Li YM, et al. Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 Isomers, tetrataisohydroquinolin derivatives. Biol Pharm Bull, 2008, 6: 1258-1264.
-
(2008)
Biol Pharm Bull
, vol.6
, pp. 1258-1264
-
-
Yan, F.1
Jiang, Y.2
Li, Y.M.3
|